Matthew P. Young
2014
In 2014, Matthew P. Young earned a total compensation of $3.4M as Executive Vice President and CFO at Jazz Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $1,185,144 |
| Salary | $402,904 |
| Stock Awards | $1,563,726 |
| Other | $3,620 |
| Total | $3,405,394 |
Young received $1.6M in stock awards, accounting for 46% of the total pay in 2014.
Young also received $250K in non-equity incentive plan, $1.2M in option awards, $402.9K in salary and $3.6K in other compensation.
Rankings
In 2014, Matthew P. Young's compensation ranked 2,578th out of 13,032 executives tracked by ExecPay. In other words, Young earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,578 out of 13,032 | 80th |
Division Manufacturing | 916 out of 4,965 | 82nd |
Major group Chemicals And Allied Products | 285 out of 1,690 | 83rd |
Industry group Drugs | 221 out of 1,369 | 84th |
Industry Pharmaceutical Preparations | 182 out of 1,042 | 83rd |
Source: SEC filing on June 20, 2017.
Young's colleagues
We found five more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2014.
2014
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2014
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2014
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2014
Michael Miller
Jazz Pharmaceuticals
Senior Vice President, U.S. Commercial
2014
Kathryn Falberg
Jazz Pharmaceuticals